Recent advances in the understanding of SLE pathogenesis have shed some light on the role of T follicular helper CD4+ (TFH) cells and type-2 immunity in addition to tissue damages driven by type 1 and type 17 immunities2. The gene discussed is CD4; the disease is systemic lupus erythematosus.